We explored this prospect in mice challenged with murine melanoma SM1 cells, a BRAFV600E mutant tumor model propagated by continuous in vivo passaging17, and subsequently treated with either anti-PD-1 blocking antibody or vehicle control. Here, PDCD1 is linked to neoplasm.